This is a Study to Evaluate a Pre-confectioned Plantar Insole for the Treatment of Plantar Heel Pain
Launched by ENTE OSPEDALIERO CANTONALE, BELLINZONA · Apr 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special type of insole designed to help people who suffer from plantar heel pain, also known as plantar fasciitis. The study aims to see if using this insole for one year can improve mobility and help people return to their normal daily activities more quickly. If you or someone you know has been dealing with plantar fasciitis for at least six months and hasn’t found relief from other treatments, this trial might be a good fit.
To participate, you need to be between 18 and 70 years old and willing to follow the trial guidelines. Unfortunately, people with uncontrolled diabetes, rheumatoid arthritis, past foot surgeries, or certain other health issues may not be eligible. Participants will be asked to wear the insole and report their experiences over the year, helping researchers understand how effective this treatment can be. If you have further questions or are interested in joining, please reach out for more information!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female adults
- • Age ranging 18 to 70 years
- • Patients with a history of at least 6 months of plantar fasciitis resistant to other conventional therapies
- • Willingness and ability to participate in the trial
- • Informed Consent signed by the subject
- Exclusion Criteria:
- • Diabetes mellitus not controlled pharmacologically
- • Rheumatoid arthritis
- • Previous foot surgery
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the participant, etc.
About Ente Ospedaliero Cantonale, Bellinzona
Ente Ospedaliero Cantonale (EOC) in Bellinzona is a prominent healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a key sponsor of clinical trials, EOC focuses on fostering innovative healthcare solutions and improving patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and collaboration, EOC plays an essential role in the development of new therapies and medical practices, leveraging its expertise and resources to contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lugano, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported